Search the Newsreel

MDU Resources (NYSE: MDU) Q2 2026 earnings, cash flow and rate case update

Amdocs (DOX) insider plans $1.86M sale of 33,584 shares after prior disposals

Amdocs Limited insider Tamar Rappaport Dagim plans to sell 33,584 ordinary shares worth approximately $1.86 million through Oppenheimer & Co. Inc. These shares were acquired on November 11, 2023, through the vesting of RSUs without cash consideration. The filing also discloses prior sales by …

PomDoctor Ltd (POM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for PomDoctor Ltd (POM), detailing future EPS and revenue growth estimates. It includes a snapshot of the company's current stock performance, market capitalization, and a comparison with peer companies like Meta Platforms and Alphabet. The financial forecasting section …

Camden Property Trust Revenue Breakdown – TRADEGATE:CAL

Camden Property Trust (TRADGATE:CAL) generated 1.34 billion EUR in revenue last year, primarily from its Same Store Communities segment, which contributed 1.24 billion EUR. The United States was the largest geographical contributor, accounting for 1.37 billion EUR. This data provides a breakdown of the …

Amdocs Limited 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:DOX) 2026-08-06

Amdocs Limited (NASDAQ:DOX) released its Q3 2026 earnings call presentation, following a quarter where its EPS of $1.84 missed estimates by $0.00, but revenue of $1.17 billion, up 2.66% year-over-year, beat expectations by $1.63 million. The company's slide deck provides further details on these …

MDU Resources Group, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:MDU) 2026-08-06

MDU Resources Group reported improved second-quarter earnings, with net income rising to $21.3 million, or $0.10 per share, driven by new utility rates, customer growth, and renewable investments. The company is advancing its Bakken East Pipeline project, estimated to cost $2.7 billion to $3.2 …

LifeMD, Inc. Q2 2026: Revenue $47.28M, EPS $(0.16) — 10-Q Summary

LifeMD, Inc. reported its second-quarter 2026 results, showing a revenue of $47.28 million, a 3.6% decrease year-over-year, and a net loss of $7.86 million, significantly wider than the previous year's loss. The diluted loss per share was $(0.16). Despite a decline in online product …

Camden Property Trust stock underperforms Thursday when compared to competitors

Camden Property Trust (CPT) shares fell 1.05% on Thursday, closing at $110.74, underperforming the broader market. This decline occurred during a generally down day for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also posting losses. The stock's …

BlackRock pays $1.6B for Camden’s last SoCal apartments

BlackRock has acquired 11 apartment complexes from Camden Property Trust in Southern California for $1.6 billion, marking Camden's exit from the state. This transaction, involving 3,620 units across multiple counties, is one of the largest multifamily deals in the region's history. The purchase was …

Amdocs Q3 Earnings Meet Estimates as Managed Services Hit Record

Amdocs Limited DOX reported third-quarter fiscal 2026 non-GAAP earnings of $1.84 per share, which increased 7% on a year-over-year basis. The figure matched the Zacks Consensus Estimate. Amdocs' fiscal third-quarter revenues of $1.175 billion missed the consensus mark by 0.04%. The top line increased …

MDU Resources Group (NYSE:MDU) Issues FY 2026 Earnings Guidance

MDU Resources Group (NYSE:MDU) has issued its FY 2026 earnings guidance, projecting an EPS of $0.93-$1.00, which aligns with the analyst consensus of $0.98. The company's shares rose 1.6% to $20.34 following the announcement, and it maintains a "Hold" rating from analysts with an …

FMR LLC boosts disclosure of 7.9% Camden National Corp (CAC) ownership stake

FMR LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 1,330,676.75 shares, or 7.9%, of Camden National Corp (CAC) common stock. The filing indicates FMR LLC holds sole voting power over 1,330,065 shares and sole dispositive power over all 1,330,676.75 shares. …

FMR LLC and Abigail P. Johnson disclose 9.4% Amdocs Limited (DOX) ownership

FMR LLC and Abigail P. Johnson have reported beneficial ownership of 9.4% of Amdocs Limited's common stock, totaling 10,032,312.93 shares. FMR LLC holds sole voting power over 8,783,014.17 shares and sole dispositive power over all 10,032,312.93 shares, while Abigail P. Johnson also has sole …

Earnings Flash (MDU) MDU Resources Group, Inc. Reports Q2 Revenue $375.2M, vs. FactSet Est of $396.6M

MDU Resources Group, Inc. (MDU) announced its Q2 2026 revenue of $375.2 million, which fell short of the FactSet estimate of $396.6 million. Despite missing revenue estimates, the company's Q2 EPS of $0.10 surpassed the FactSet estimate of $0.07. MDU Resources Group reaffirmed its …

MDU Resources (NYSE:MDU) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings

MDU Resources (NYSE:MDU) reported Q2 CY2026 earnings, with sales of $375.2 million falling below analyst estimates despite a 6.8% year-on-year increase. However, the company's GAAP EPS of $0.10 exceeded consensus estimates by 29.3%. Full-year EPS guidance at the midpoint missed analyst estimates by 1.2%, …

Optimum Transforms Customer Bill Experience with AI-Enhanced Platform Powered by Amdocs aOS Cognitive Core

Optimum has launched a redesigned customer billing experience, powered by Amdocs Bill Experience and Amdocs' aOS Cognitive Core, to provide greater transparency and self-service. The new platform uses AI-driven automation to simplify bills with clearer explanations, visual insights, and proactive bill guidance, aiming to …

Camden Property Trust Sells $1.6B Multifamily Portfolio in Southern California

Camden Property Trust has sold a portfolio of 11 multifamily properties in Southern California for $1.6 billion to an entity managed by BlackRock Inc. The portfolio, comprising 3,620 units, had a 96 percent occupancy rate at the time of sale. JLL Capital Markets brokered …

Will Amdocs' (DOX) 10-Year Liberty Latin America AI Deal Offset Weaker Q3 Profitability?

Amdocs Limited reported mixed Q3 2026 results with revenue growth but a significant drop in net income and diluted EPS. Despite this, the company secured a 10-year AI-enabled modernization deal with Liberty Latin America and other projects, highlighting a growing pipeline in AI and …

Amdocs (NASDAQ: DOX) Q3 2026: agentic strategy, Liberty deal, GAAP cut

Amdocs (NASDAQ: DOX) reported Q3 fiscal 2026 revenue of $1.175 billion and non-GAAP diluted EPS of $1.84. The company announced a new 10-year partnership with Liberty Latin America, leveraging its "agentic" growth strategy and aOS Agentic Telco Operating System. While non-GAAP EPS guidance for …

(LFMDP) Risk Channels and Responsive Allocation

This article provides an AI-driven analysis of LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (NASDAQ: LFMDP), noting a neutral sentiment and a wait-and-see approach. It highlights an exceptional 12.0:1 risk-reward setup targeting a 3.6% gain, with specific trading strategies for position trading, …

LifeMD Reports Second Quarter 2026 Results, Reaches Branded GLP-1 Transition Milestone and Raises Full-Year Guidance

LifeMD, Inc. announced its Q2 2026 financial results, reporting revenues of $47.3 million and a sequential improvement in adjusted EBITDA loss to $3.5 million. The company is transitioning its weight management program to branded GLP-1 therapies, which now account for 95% of new patients, …

Amundi Has $7.77 Million Stock Position in Camden Property Trust $CPT

Camden National (NASDAQ: CAC) doubles year-to-date 2026 earnings

LifeMD (NASDAQ:LFMD) Issues Quarterly Earnings Results, Misses Expectations By $0.01 EPS

LifeMD (NASDAQ:LFMD) reported its quarterly earnings, missing analyst expectations with an adjusted EPS of negative $0.16 against a consensus of negative $0.15, and revenue of $47.28 million, falling short of the $49.16 million estimate. The telehealth company also reduced its full-year 2026 guidance due …

LifeMD (NASDAQ:LFMD) Shares Slide After Q2 Revenue and EPS Miss

LifeMD (NASDAQ:LFMD) reported disappointing Q2 2026 results, missing both revenue and non-GAAP EPS consensus estimates. The virtual care and pharmacy services company posted revenue of $47.3 million against a $50.1 million consensus, and a non-GAAP loss per share of $0.16 compared to an expected …

LifeMD (NASDAQ: LFMD) posts Q2 $47.3M revenue, cuts 2026 guidance

LifeMD reported Q2 2026 telehealth revenue of $47.3 million, a 4% year-over-year decrease, though within guidance, as it transitions weight-management patients to branded GLP-1 therapies and longer subscriptions. The company increased active subscribers by 20% to approximately 356,000, and gross margin expanded to 89%. …

mDR Limited Revenue Breakdown – SGX:Y3D

LifeMD earnings missed by $0.06, revenue fell short of estimates

Amdocs (DOX) Stock Looks Undervalued After A 36% Fall

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Amdocs stock has fallen 35.7% over the past year, yet the broader valuation checks still lean cheap, which raises a clear question about how …

LifeMD Q2 Results: Revenue falls 3%, adjusted EBITDA loss widens

LifeMD reported a 3% year-over-year revenue decline to $47.3 million in Q2 2026, while its adjusted EBITDA swung to a $3.5 million loss, primarily due to higher customer acquisition costs and a strategic shift to branded GLP-1 therapies. Despite the revenue dip, gross margin …

A1 Austria Completes Billing, Charging and Catalog Transformation with Amdocs

Amdocs announced that A1 Austria has successfully completed a multi-year transformation of its monetization environment, deploying Amdocs Charging, Billing, and Catalog. This modernization, with components on Microsoft Azure, aims to simplify operations, improve performance, and enable future growth by streamlining processes and reducing costs. …

Earnings call transcript: LifeMD posts Q2 revenue miss, shares sink in after-hours

LifeMD (LFMD) reported a Q2 revenue miss of $47.3 million against an analyst forecast of $49.15 million, alongside an adjusted EBITDA loss and a lowered full-year 2026 outlook, causing shares to drop over 17% in after-hours trading. Despite the financial setbacks, the company highlighted …

LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates

LifeMD, Inc. (LFMD) reported a Q2 loss of $0.16 per share, which was an earnings surprise of +20.00% compared to the Zacks Consensus Estimate of a $0.2 loss. However, the company missed revenue estimates, posting $47.28 million against an estimated $49.10 million. Despite outperforming …

LifeMD Q2 2026 slides tout AI platform, results miss targets

LifeMD presented an investor overview in August 2026, highlighting its AI-enabled virtual care platform and growth strategy, despite second-quarter results missing Wall Street expectations. The company's shares fell significantly following the earnings release, nearing its 52-week low. The presentation emphasized LifeMD's transformation into a …

Amdocs (DOX) Releases Q3 2026 Earnings: Revenue Growth but Profit Declines

Lumen Extends Multi-Cloud Strategy with Amdocs, Modernizing Enterprise Service Orchestration

Lumen Technologies is expanding its multi-cloud strategy by collaborating with Amdocs to modernize its enterprise service orchestration and order management platform on Amazon Web Services (AWS). This initiative builds on previous migrations to Google Cloud and Microsoft Azure, aiming to create a resilient, cloud-native …